Polycystic ovary syndrome: new insights on the puzzle of adiposity, chronic low-grade inflammation and metabolic disturbances
Open Access
- 4 March 2020
- journal article
- editorial
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 64 (1) , 2-3
Abstract
In this issue of AE&M, Cardoso and cols. ( 3 ) report the associations between adiposity, metabolic traits and adipose tissue-secreted products in a sample of women with PCOS compared to controls. The subjects were stratified according to body fat percentage (BFP) classes and both PCOS and controls were similar regarding age, body mass index (BMI), waist-to-hip ratio, body fat and lipid profile in each BFP class. In turn, considering the same body fat class, insulin-resistance markers (insulin and HOMA-IR) as well as testosterone levels were higher in PCOS compared to controls. Leptin levels were similarly higher and adiponectin levels were lower in both PCOS and control subgroups presenting greater adiposity. In contrast, in these subjects with greater body fat, inflammation markers – TNFα and IL6 levels were higher in PCOS compared to controls. The outcomes of this study, analyzing adipokine levels associated to body fat instead of BMI, expand previous published data about leptin circulating levels in PCOS and controls that indicated a direct relationship between leptin and the amount of body fat, being significantly increased in overweight or obese subgroups, in the presence of PCOS or not ( 4 , 5 ). Conversely, current data are not yet conclusive in relation to adiponectin serum levels, as also cited by Cardoso and cols., and other studies have found lower adiponectin levels in women with PCOS compared with controls ( 6 ). The disagreement among studies may be related to distinct factors, such as ethnicity or to differences in the methods of adiponectin determination. Recently, the measurement of high molecular weight-active adiponectin forms instead of total adiponectin has shown to increase the accuracy of assessments of the relationship between adiponectin and insulin resistance in PCOS ( 7 , 8 ). Interestingly, the results of the Cardoso et al study also reinforce the notion that higher/dysfunctional fat mass in PCOS may release inflammatory mediators, such as TNF and IL6, contributing to pathophysiological mechanisms related to the development of metabolic and reproductive dysfunctions of the syndrome ( 2 , 9 ).Keywords
This publication has 19 references indexed in Scilit:
- Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional studyPLOS ONE, 2017
- Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-AnalysisNutrients, 2015
- Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndromeReproduction, 2015
- Obesity and vitamin D deficiency: a systematic review and meta‐analysisObesity Reviews, 2015
- Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysisTumor Biology, 2014
- Adipocyte biology in polycystic ovary syndromeMolecular and Cellular Endocrinology, 2013
- Vitamin D in the aetiology and management of polycystic ovary syndromeClinical Endocrinology, 2012
- Inflammation in Polycystic Ovary Syndrome: Underpinning of insulin resistance and ovarian dysfunctionSteroids, 2012
- Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndromeFertility and Sterility, 2011
- Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndromeFertility and Sterility, 2002